Observational studyESC heart failure2024
Characteristics of patients admitted with heart failure: Insights from the first Malaysian Heart Failure Registry.
Observational study in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The Association Between Cancer Incidence and Heart Failure: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- Guideline-directed medical therapy in older adults with heart failure; Are there differences across age group?BMC geriatrics · 2026Article
- Time to Ditch 'Diurese & Discharge'- Spotlight on Heart Failure in Malaysia.Journal of geriatric cardiology : JGC · 2026Article
- Translating the 2023 Malaysian Heart Failure Clinical Practice Guidelines (5th Edition) into primary care practice.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2026Article
- Time to Readmission and Its Prognostic Factors among Hospitalised Heart Failure Patients.The Malaysian journal of medical sciences : MJMS · 2025Article
- Clinical characteristics, treatment patterns, & outcomes of heart failure: A comparative analysis across age groups from the heart failure registry in India.The Indian journal of medical research · 2025Article
- The Epidemiology of Ascites in a Multi-Ethnic Asian Population.JGH open : an open access journal of gastroenterology and hepatology · 2025Article
- Trajectory of health-related quality of life during and after hospitalisation due to worsening of heart failure.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Article
- A comparative review of current international atrial fibrillation guidelines from a primary care perspective.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2025Review
- Characteristics of patients admitted with heart failure: Insights from the first Malaysian Heart Failure Registry.ESC heart failure · 2024Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
aimsHeart failure (HF) is a growing health problem, yet there are limited data on patients with HF in Malaysia. The Malaysian Heart Failure (MY-HF) Registry aims to gain insights into the epidemiology, aetiology, management, and outcome of Malaysian patients with HF and identify areas for improvement within the national HF services. METHODS AND
resultsThe MY-HF Registry is a 3-year prospective, observational study comprising 2717 Malaysian patients admitted for acute HF. We report the description of baseline data at admission and outcomes of index hospitalization of these patients. The mean age was 60.2 ± 13.6 years, 66.8% were male, and 34.3% had de novo HF. Collectively, 55.7% of patients presented with New York Heart Association (NYHA) Class III or IV; ischaemic heart disease was the most frequent aetiology (63.2%). Most admissions (87.3%) occurred via the emergency department, with 13.7% of patients requiring intensive care, and of these, 21.8% needed intubation. The proportion of patients receiving guideline-directed medical therapy increased at discharge (84.2% vs. 93.6%). The median length of stay (LOS) was 5 days, and in-hospital mortality was 2.9%. Predictors of LOS and/or in-hospital mortality were age, NYHA class, estimated glomerular filtration rate, and comorbid anaemia. LOS and in-hospital mortality were similar regardless of ejection fraction.
conclusionsThe MY-HF Registry showed that the HF population in Malaysia is younger, predominantly male, and ischaemic-driven and has good prospects with hospitalization for optimization of treatment. These findings suggest a need to reassess current clinical practice and guide resource allocation to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.